Key facts
- It has raised $950K; the latest was Early Stage VC ($950K) in Jan 2025.
- Notable investors include Ecosphere Ventures, Ideaship, John Ballantyne, Pack Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Decycle Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Decycle Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Decycle Bio
Developer of a cell-free biomanufacturing platform intended to produce sustainable chemicals from industrial outputs. The company's platform uses a proprietary AI-driven pathway design system to evaluate thousands of potential biocatalytic routes, engineers multi-enzyme pathways and novel enzymes for non-natural substrates, converts feedstocks and applies process engineering, enabling chemical buyers and industrial feedstock owners to obtain petrochemical-equivalent products.
- Sector
- Materials and Resources
- HQ
- Seattle, WA, United States
- Founded
- 2024
- Employees
- 7
- Website
- decycle.bio/
- Ownership
- Privately Held (backing)
Decycle Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Decycle Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Decycle Bio in its N-PORT filings yet. We sweep new filings monthly.